Matthew D Cox

US Patent:

8153651, Apr 10, 2012

Filed:

Nov 13, 2008

Appl. No.:

12/742425

Inventors:

Matthew Cox - San Francisco CA, US
Donogh John Roger O'Mahony - San Mateo CA, US
Maria De Los Angeles Estiarte-Martinez - San Francisco CA, US
Tadashi Kawashima - Sandwich, GB
Satoshi Nagayama - Sandwich, GB
Yuji Shishido - Sandwich, GB
Hirotaka Tanaka - Sandwich, GB
Matthew Alexander James Duncton - San Bruno CA, US
Andrew Antony Calabrese - Sandwich, GB

Assignee:

Evotec AG - Hamburg

International Classification:

A01N 43/42
A61K 31/44
C07D 471/02

US Classification:

514299, 546122

Abstract:

Compounds are disclosed that have a formula represented by the following:.

US Patent:

8163901, Apr 24, 2012

Filed:

Jan 9, 2009

Appl. No.:

12/811972

Inventors:

Matthew Duncton - San Bruno CA, US
Donogh John Roger O'Mahony - San Mateo CA, US
Matthew Cox - San Francisco CA, US
Maria De Los Angeles Estiarte-Martinez - San Francisco CA, US

Assignee:

Evotec AG - Hamburg

International Classification:

C07D 407/12
C07D 513/04
C07D 401/12
C07D 491/052
C07D 498/04
A61K 31/4709

US Classification:

544 91, 544105, 546114, 546115, 546167, 5483625, 5142305, 514301, 514302, 514314, 514406

Abstract:

Compounds are disclosed that have a formula represented by the following:.

US Patent:

20110257208, Oct 20, 2011

Filed:

Nov 17, 2009

Appl. No.:

13/130051

Inventors:

Matthew Duncton - San Bruno CA, US
Donogh John Roger O'mahony - San Mateo CA, US
Matthew Cox - San Francisco CA, US

International Classification:

A61K 31/519
A61P 25/00
A61P 25/24
A61P 25/18
A61P 11/00
A61P 17/06
A61P 9/10
A61P 9/12
A61P 21/00
A61P 27/06
A61P 37/02
A61P 13/00
A61P 1/08
A61P 35/00
A61P 25/22
C07D 487/04

US Classification:

5142651, 544280

Abstract:

Compounds are disclosed that have formula I: where A, B, L, W, Y, R, and Rare as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, anxiety, depression, inflammation, cognitive disorders, weight and eating disorders, Parkinson's disease, Alzheimer's disease, spasticity, addiction, glaucoma, and others.

US Patent:

20120088746, Apr 12, 2012

Filed:

May 10, 2007

Appl. No.:

12/227197

Inventors:

Yuji Shishido - Aichi-ken, JP
Kazunari Nakao - Aichi-ken, JP
Satoshi Nagayama - Aichi-ken, JP
Hirotaka Tanaka - Aichi-ken, JP
Matthew Alexander James Duncton - San Francisco CA, US
Matthew Cox - San Francisco CA, US
John Kincaid - San Francisco CA, US
Kiran Sahasrabudhe - Newark CA, US
Maria de Los Angeles Estiarte-Martinez - San Francisco CA, US

Assignee:

PFIZER INC. - New York NY
RENOVIS, INC. - South San Francisco CA

International Classification:

A61K 31/397
C07D 213/76
C07D 215/48
C07D 215/54
C07D 295/155
C07D 205/04
A61K 31/18
A61K 31/44
A61K 31/47
A61K 31/402
A61K 31/5375
A61K 31/451
A61P 19/02
A61P 19/08
A61P 1/00
A61P 25/16
A61P 29/00
A61P 25/28
A61P 25/18
A61P 25/22
A61P 25/08
A61P 13/00
A61P 13/12
A61P 13/10
A61P 9/12
A61P 35/00
A61P 3/04
A61P 3/00
A61P 17/06
A61P 17/14
A61P 17/04
A61P 9/10
A61P 11/00
A61P 11/06
A61P 25/00
C07C 311/16

US Classification:

51421001, 564 99, 546312, 546169, 548577, 544159, 548950, 546205, 514605, 514352, 514311, 514429, 5142395, 514319

Abstract:

Compounds are disclosed that have a formula represented by the following: Formula (I). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

US Patent:

20130007371, Jan 3, 2013

Filed:

Jun 28, 2011

Appl. No.:

13/171226

Inventors:

Israel Hilerio - Kenmore WA, US
David J. Sheldon - Seattle WA, US
David Vaughn Winkler - Seattle WA, US
Matthew R. Cox - Kirkland WA, US
Jonathan A. Silvera - Seattle WA, US
Ivan D. Pashov - Woodinville WA, US
Martin A. Chisholm - Bellevue WA, US
Dany Joly - Vancouver, CA
Victor Ngo - Kirkland WA, US
Adam U. Herchenroether - Seattle WA, US
Katerina V. Sedova - Seattle WA, US
Kedar Sanjeev Hirve - Kent WA, US
Karen Elizabeth Parker Anderson - Sammamish WA, US

International Classification:

G06F 12/08

US Classification:

711133, 711118, 711E12017, 711E12009

Abstract:

Browser storage management techniques are described. In one or more implementations, inputs are received at a computing device that specify maximum aggregate sizes of application and database caches, respectively, of browser storage to be used to locally store data at the computing device. For example, the inputs may be provided using a policy, by an administrator of the computing device, and so on. The maximum aggregate sizes are set of application and database caches, respectively, of browser storage at the computing device to the sizes specified by the inputs.

US Patent:

20130045973, Feb 21, 2013

Filed:

Apr 20, 2012

Appl. No.:

13/452443

Inventors:

Matthew Duncton - San Bruno CA, US
Donogh John Roger O'Mahony - San Mateo CA, US
Matthew Cox - San Francisco CA, US
Maria De Los Angeles Estiarte-Martinez - San Francisco CA, US

International Classification:

A61K 31/4709
A61K 31/416
C07D 513/04
A61K 31/437
C07D 413/12
A61K 31/538
C07D 491/052
A61K 31/436
C07D 498/04
A61K 31/5365
A61P 29/00
A61P 25/16
A61P 25/28
A61P 25/00
A61P 25/06
A61P 25/24
A61P 25/22
A61P 25/18
A61P 25/20
A61P 13/10
A61P 11/00
A61P 11/06
A61P 25/08
A61P 11/02
A61P 37/08
A61P 13/00
A61P 19/02
A61P 1/00
A61P 37/00
A61P 9/10
A61P 19/08
C07D 405/12

US Classification:

5142305, 546167, 514314, 5483625, 514406, 546114, 514301, 544105, 546115, 514302, 544 91

Abstract:

Compounds are disclosed that have a formula represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

US Patent:

20130219383, Aug 22, 2013

Filed:

Feb 16, 2012

Appl. No.:

13/398321

Inventors:

Israel Hilerio - Kenmore WA, US
David Vaughn Winkler - Seattle WA, US
Daniel R. Thornton - Bothell WA, US
Matthew R. Cox - Kirkland WA, US
Karen Elizabeth Parker Anderson - Sammamish WA, US
Jesse D. McGatha - Sammamish WA, US
Adrian Robert Bateman - Seattle WA, US

International Classification:

G06F 9/445
G06F 15/16

US Classification:

717178

Abstract:

Various embodiments enable installable applications that are to be used on a local client machine to utilize an application cache manifest file that resides remotely, on the web, to define various resources that are to be updated and available offline after the installable application has been deployed on the local client machine Whenever the content of the manifest file is updated on the web, the installed application automatically updates its local application cache resources and allows the installed application to use those resources offline. This is done without having to install a new update of the application or burden the user with having to navigate to a location to obtain the updated content.

US Patent:

20130227272, Aug 29, 2013

Filed:

Feb 29, 2012

Appl. No.:

13/408225

Inventors:

Matthew R. Cox - Kirkland WA, US
Ivan D. Pashov - Woodinville WA, US
Billy Anders - Bothell WA, US
Jonathan A. Silvera - Seattle WA, US

Assignee:

MICROSOFT CORPORATION - Redmond WA

International Classification:

H04L 29/06

US Classification:

713151

Abstract:

Techniques described herein enable a client to store information indicating whether various hosts (e.g., servers, web domains) support a preferred security protocol, such as a False Start-modified TLS or SSL protocol. The client may then use this information to dynamically determine whether to use the preferred protocol when connecting to a particular host. When the client attempts a handshake to establish a secure connection with a host for the first time, the client does so using the preferred protocol. If the handshake fails, the client locally stores domain or other identifying information for the host so that the client may employ a non-preferred protocol in subsequent connection attempts. Thus, a client may avoid performance degradation caused by attempting a preferred-protocol connection with a host that does not support the preferred protocol. Stored information may include a time stamp enable periodic checks for host capability updates.